FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061507966> ?p ?o ?g. }

• W2061507966 abstract "Nausea and vomiting are ranked as the most severe side effects to chemotherapy by cancer patients. Twenty years ago, treatment of nausea and vomiting from chemotherapy only had moderate effect and often unpleasant side effects. The drugs used included dopamine(2)-receptor antagonists and corticosteroids alone or combined. This review summarizes the development of anti-emetic therapy, but will focus on the importance of two new classes of anti-emetics: the serotonin(3)- and the neurokinin(1)-receptor antagonists. Furthermore, evidence-based guidelines for the treatment of chemotherapy-induced nausea and vomiting will be given. The serotonin(3)-receptor antagonists, the first group of drugs developed specifically as anti-emetics, have significantly improved the prophylaxis of chemotherapy-induced emesis especially in combination with a corticosteroid. The improvement in the prophylaxis of nausea with this combination is however modest. A new group of anti-emetics, the neurokinin(1)-receptor antagonists, has now been developed, and the first drug, aprepitant, was marketed in 2003. Aprepitant increases the effect of a serotonin(3)-receptor antagonist plus a corticosteroid against acute emesis induced by highly or moderately emetogenic chemotherapy and aprepitant is also active in the protection against delayed emesis. The importance of drug-drug interactions with anti-emetics and other drugs, especially cytotoxins, through their competition for cytochrome P450 enzymes, have been studied. At present, there is no evidence that such interactions are of major clinical importance. Evidence-based clinical guidelines are now available and regularly updated, but unfortunately clinical implementation is slow. Recommendations for some types of chemotherapy-induced emesis such as delayed emesis, is based on a low level of evidence. Furthermore, the majority of clinical trials include highly selected groups of patients not permitting definite conclusions for other and more heterogeneous patient groups. Development of new anti-emetics with other mechanisms of action is awaited with interest." @default.
• W2061507966 created "2016-06-24" @default.
• W2061507966 creator A5005046506 @default.
• W2061507966 creator A5011312455 @default.
• W2061507966 date "2007-09-01" @default.
• W2061507966 modified "2023-10-04" @default.
• W2061507966 title "Anti-Emetic Therapy in Cancer Chemotherapy: Current Status" @default.
• W2061507966 cites W1487053004 @default.
• W2061507966 cites W1589773292 @default.
• W2061507966 cites W1772075674 @default.
• W2061507966 cites W1933170555 @default.
• W2061507966 cites W1950115681 @default.
• W2061507966 cites W1956681066 @default.
• W2061507966 cites W1963923143 @default.
• W2061507966 cites W1965067801 @default.
• W2061507966 cites W1973339347 @default.
• W2061507966 cites W1986765405 @default.
• W2061507966 cites W1989264162 @default.
• W2061507966 cites W1994776603 @default.
• W2061507966 cites W1996898160 @default.
• W2061507966 cites W1997373870 @default.
• W2061507966 cites W1998110762 @default.
• W2061507966 cites W2002685742 @default.
• W2061507966 cites W2006331073 @default.
• W2061507966 cites W2006839453 @default.
• W2061507966 cites W2020758186 @default.
• W2061507966 cites W2029309368 @default.
• W2061507966 cites W2040274552 @default.
• W2061507966 cites W2046417971 @default.
• W2061507966 cites W2051675546 @default.
• W2061507966 cites W2071655329 @default.
• W2061507966 cites W2074327730 @default.
• W2061507966 cites W2085424175 @default.
• W2061507966 cites W2087208740 @default.
• W2061507966 cites W2103568054 @default.
• W2061507966 cites W2105467170 @default.
• W2061507966 cites W2107985230 @default.
• W2061507966 cites W2120978512 @default.
• W2061507966 cites W2131444830 @default.
• W2061507966 cites W2155726820 @default.
• W2061507966 cites W2158036326 @default.
• W2061507966 cites W2160465588 @default.
• W2061507966 cites W2164502847 @default.
• W2061507966 cites W2164832682 @default.
• W2061507966 cites W2165395427 @default.
• W2061507966 cites W2324983656 @default.
• W2061507966 cites W2327612061 @default.
• W2061507966 cites W2336274156 @default.
• W2061507966 cites W252362330 @default.
• W2061507966 cites W2578694077 @default.
• W2061507966 cites W3003396282 @default.
• W2061507966 cites W4230593281 @default.
• W2061507966 cites W4237507306 @default.
• W2061507966 cites W4239374860 @default.
• W2061507966 doi "https://doi.org/10.1111/j.1742-7843.2007.00122.x" @default.
• W2061507966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17697032" @default.
• W2061507966 hasPublicationYear "2007" @default.
• W2061507966 type Work @default.
• W2061507966 sameAs 2061507966 @default.
• W2061507966 citedByCount "67" @default.
• W2061507966 countsByYear W20615079662012 @default.
• W2061507966 countsByYear W20615079662013 @default.
• W2061507966 countsByYear W20615079662014 @default.
• W2061507966 countsByYear W20615079662015 @default.
• W2061507966 countsByYear W20615079662016 @default.
• W2061507966 countsByYear W20615079662017 @default.
• W2061507966 countsByYear W20615079662018 @default.
• W2061507966 countsByYear W20615079662019 @default.
• W2061507966 countsByYear W20615079662020 @default.
• W2061507966 countsByYear W20615079662021 @default.
• W2061507966 countsByYear W20615079662022 @default.
• W2061507966 countsByYear W20615079662023 @default.
• W2061507966 crossrefType "journal-article" @default.
• W2061507966 hasAuthorship W2061507966A5005046506 @default.
• W2061507966 hasAuthorship W2061507966A5011312455 @default.
• W2061507966 hasConcept C118303440 @default.
• W2061507966 hasConcept C126322002 @default.
• W2061507966 hasConcept C143998085 @default.
• W2061507966 hasConcept C170493617 @default.
• W2061507966 hasConcept C202871150 @default.
• W2061507966 hasConcept C2776533618 @default.
• W2061507966 hasConcept C2776694085 @default.
• W2061507966 hasConcept C2777452722 @default.
• W2061507966 hasConcept C2780574406 @default.
• W2061507966 hasConcept C2780580376 @default.
• W2061507966 hasConcept C2780852908 @default.
• W2061507966 hasConcept C2780884295 @default.
• W2061507966 hasConcept C71924100 @default.
• W2061507966 hasConcept C98274493 @default.
• W2061507966 hasConceptScore W2061507966C118303440 @default.
• W2061507966 hasConceptScore W2061507966C126322002 @default.
• W2061507966 hasConceptScore W2061507966C143998085 @default.
• W2061507966 hasConceptScore W2061507966C170493617 @default.
• W2061507966 hasConceptScore W2061507966C202871150 @default.
• W2061507966 hasConceptScore W2061507966C2776533618 @default.
• W2061507966 hasConceptScore W2061507966C2776694085 @default.
• W2061507966 hasConceptScore W2061507966C2777452722 @default.
• W2061507966 hasConceptScore W2061507966C2780574406 @default.
• W2061507966 hasConceptScore W2061507966C2780580376 @default.
• W2061507966 hasConceptScore W2061507966C2780852908 @default.

• next